menu search

High costs and macro worries drag cemex down

Cemex has underperformed, with investors fretting about both a weaker demand environment in 2023 and underwhelming profitability at this global cement...

December 12, 2022, 9:21 pm

 the waiting game, us cpi and fomc meeting on tap, yellen, binance under the spotlight

It was supposed to be a very quiet stock market session ahead of a pivotal inflation report and the last FOMC meeting of the year. ​ There was a ...

December 12, 2022, 8:46 pm

Hightower's stephanie link on lam research buy: a lot of the bad news is priced in

Stephanie Link, Hightower Advisors chief investment strategist, joins 'Closing Bell: Overtime' to discuss her late-day buy of Lam Research....

December 12, 2022, 6:00 pm

Energy: ‘there's a lot of longs' ahead of china's re-opening plans, analyst says

Blue Line Futures President Bill Baruch joins Yahoo Finance Live anchors Jared Blikre and Seana Smith to weigh in on U.S. gas prices, what to expect f...

December 12, 2022, 4:16 pm

Nustar: 10% yield and 2x coverage are not tempting enough

NuStar has delivered good results in 2022 considering the challenges it has had to face. We have generally not found the common shares attractive due ...

December 12, 2022, 3:51 pm

As clothing shoppers get pickier, goldman sachs likes these retailers' odds for 2023

Shoppers are getting choosier and the rush to refresh wardrobes is slowing, Goldman Sachs analysts say, leading to what is likely to be an uneven 2023...

December 12, 2022, 2:50 pm

Hong kong could open further in january: capture with kba

Chinese local news sources reported over the weekend that Hong Kong could be part of a “large-scale” pilot...

December 12, 2022, 1:39 pm

Google: why is no one talking about palm

There has been a lot of talk in recent weeks about whether OpenAI's ChatGPT and the underlying GPT-3 la...

December 12, 2022, 1:38 pm

Cardiol therapeutics kicks off a multi-center phase ii pilot study of cardiolrx for the treatment of recurrent pericarditis

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc revealed that it had initiated a Phase II open-label pilot...

December 12, 2022, 11:59 am

Docusign stock just got a whole lot more interesting -- or did it?

Investors should not jump the gun just yet....

December 12, 2022, 11:00 am

Apple agrees to let workers speak out about harassment and discrimination — ‘this gives me a lot of hope for all laborers'

Apple Inc. is promising to limit its use of nondisclosure agreements and clarifying its policies on employees' right to speak out in cases of discrimi...

December 12, 2022, 8:15 am

Altagas vs. algonquin: discounted utilities with ominous similarities

AltaGas & Algonquin have a lot of similarities. The companies have assets in two sectors but there are ...

December 12, 2022, 8:00 am

Albemarle corporation to host corporate strategy webcast on tues., jan. 24, 2023

CHARlotTE, N.C. , Dec. 12, 2022 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the glob...

December 12, 2022, 6:45 am

Dollar rises slightly as markets turn cautious; fed, ecb, boe and snb to hike

Dollar rises mildly in Asian session as investors turned cautious. Euro is also firmer but Sterling is on the softer side together with Aussie and Kiw...

December 12, 2022, 4:31 am

Elon musk mentions major threat to bitcoin’s clambering price as analyst predicts btc nosediving before surging

The cryptocurrency industry has been through a lot this year and another interest rate hike from the Fe...

December 12, 2022, 3:44 am

Does lululemon's 12% drop signal bad news for clothing retailers?

Luxury athletic clothing retailer Lululemon gapped down 12%, after warning of higher-than-anticipated i...

December 12, 2022, 1:01 am

Vincerx pharma presents preclinical data on vip943 in acute myeloid leukemia models at the 64th american society of hematology annual meeting 2022

Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conjugate (ADC), demonstrated superiority with sign...

December 11, 2022, 3:05 pm

1 etf that could make you a stock market millionaire with little to no effort

With the right investments, you could potentially make a lot of money in the stock market....

December 11, 2022, 7:30 am

Macerich's investor day highlights: reinventing the mall

Macerich recently hosted its 2022 investor day, and we found the presentation to be convincing, especially how Macerich is repositioning its propertie...

December 11, 2022, 3:15 am

Chicken soup: undervalued and expecting a lot of fcf

The purpose of Chicken Soup is to sustain and develop its on-demand video streaming platform. If management continues to acquire, assess, and store da...

December 10, 2022, 11:18 pm


Search within

Pages Search Results: